Clinical Trial Update: Montelukast as a Controller of Atopic Syndrome [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating montelukast for control of atopic syndrome has completed, studying its effects in seasonal allergic rhinitis, allergic conjunc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis
• Asthma
• Atopic Dermatitis
• Seasonal Allergic Rhinitis

Drugs mentioned

• Montelukast (Montelukast)

Snippet

Sponsor: University of Helsinki | Conditions: Seasonal Allergic Rhinitis, Allergic Conjunctivitis | Phase 4 | Status: COMPLETED